Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: Role of glutamate

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 301, Issue 3, 2011, Pages

  Fanne, Rami Abu ^a   Nassar, Taher ^a   Heyman, Samuel N ^a   Hijazi, Nuha ^a   Higazi, Abd Al Roof ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain damage; Glutamate; Stroke

Indexed keywords

GLUCAGON; GLUCOSE; GLUTAMIC ACID; INSULIN; OXALOACETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; DRUG MEGADOSE; GLUCOSE METABOLISM; HISTOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TRAUMATIC BRAIN INJURY;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; GLUCAGON; GLUTAMIC ACID; HYPOGLYCEMIC AGENTS; INFARCTION, MIDDLE CEREBRAL ARTERY; INSULIN; MALE; NEUROPROTECTIVE AGENTS; OXALOACETATE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 80052399437     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00058.2011     Document Type: Article

References (47)

1. Abu Fanne R, Nassar T, Mazuz A, Waked W, Heyman N, Goelman G, Higazi A. Neuroprotection by glucagon: Role of gluconeogenesis. J Neurosurg 114: 85-91, 2010.
2. Abu Fanne R, Nassar T, Yarovoi S, Rayan A, Lamensdorf I, Karak-oveski M, Vadim P, Jammal M, Cines D, Higazi A. Blood-brain barrier permeability and tPA-mediated neurotoxicity. Neuropharmacology 58: 972-980, 2010.
3. Adams H, Del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgen-stern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF; American Heart Association, American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Guidelines for the early management of adults with ischemic stroke. Stroke 38: 1655-1711, 2007.
4. Armstead WM, Nassar T, Akkawi S, Smith DH, Chen XH, Cines DB, Higazi A. Neutralizing the neurotoxic effects of exogenous and endogenous tPA. Nat Neurosci 9: 1150-1155, 2006.
5. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 34: 2208-2214, 2003.
6. Bederson J, Pitts L, Tsuji M, Nishimura M, Davis R, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and devel- opment of a neurologic examination. Stroke 17: 472-476, 1986.
7. Bendotti C, Tortarolo M, Suchak KS, Calvaresi N, Carvelli L, Bastone A, Rizzi M, Rattray M, TM. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 79: 737-746, 2001.
8. Bilotta F, Caramia R, Cernak I, Paoloni F, Doronzio A, Cuzzone V, Santoro A, Rosa G. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care 9: 159-166, 2008.
9. Blanca Fuentes B, Castillo J, San Jose B, Leira R, Serena J, Vivancos J, Dávalos A, Gil Nuñez A, Egido J, Díez-Tejedor E. The prognostic value of capillary glucose levels in acute stroke: the GLycemia in Acute Stroke (GLIAS) study. Stroke 40: 562-568, 2009.
10. Bômont L, MacKenzie E. Neuroprotection after focal cerebral ischaemia in hyperglycaemic and diabetic rats. Neurosci Lett 197: 53-56, 1995.
11. Brockman RP, Bergman EN, Joo Pk, Ganns JG. Effects of glucagon and insulin on net hepatic metabolism of glucose precursors in sheep. Am J Physiol 229: 1344-1350, 1975.
12. Bruno A, Levine S, Frankel M, Brott T, Lin Y, Tilley B, Lyden P, Broderick J, Kwiatkowski T, Fineberg S. Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology 59: 669-674, 2002.
13. Bullock R, Zauner A, Woodward J, Young H. Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke 26: 2187-2189, 1995.
14. Campos F, Sobrino T, Ramos-Cabrer P, Argibay B, Agulla J, Perez-Mato M, Rodryguez-Gonzalez R, Brea D, Castillo J. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. J Cereb Blood Flow Metab 26: 1-9, 2011.
15. Capes S, Hunt D, Malmberg K, Pathak P, Gerstein H. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 34: 2426-2432, 2001.
16. Castillo J, Dávalos A, Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet 349: 79-83, 1997.
17. Chandra S, White R, Everding D, Feuerstein G, Coatney R, Sarkar S, Barone F. Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia. Pharmacology 58: 292-299, 1999.
18. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32: 2682- 2688, 2001.
19. de Courten-Myers G, Myers RE, Schoolfield L. Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats. Stroke 19: 623-630, 1988.
20. Durham H, Truett G. Development of insulin resistance and hyperphagia in Zucker fatty rats. Am J Physiol Regul Integr Comp Physiol 290:R652-R658, 2006.
21. Fuentes B, Ortega-Casarrubios M, SanJose B, Castillo J, Leira R, Serena J, Dávalos J, Gil-Nuñz A, Egido J, Díez-Tejedor E. Persistent hyperglycemia 155 mg/dl in acute ischemic stroke patients: How well are we correcting it? Implications for outcome. Stroke 41: 2362-2365, 2011.
22. Gottlieb M, Wang Y, Teichberg V. Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem 87: 119-126, 2003.
23. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti KM. Glucose-potassium- insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 6: 397- 406, 2007.
24. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti KG. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 6: 397- 406, 2007.
25. Haratz S, Tanne D. Diabetes, hyperglycemia and the management of cerebrovascular disease. Curr Opin Neurol 24: 81-88, 2011.
26. Kaarisalo M, Raiha I, Sivenius J, Immonen-Raiha P, Lehtonen A, Sarti C, Mahonen M, Torppa J, Tuomilehto J, Salomaa V. Diabetes worsens the outcome of acute ischemic stroke. Diabetes Res Clin Pract 69: 293-298, 2005.
27. Kernan W, Inzucchi S. Type 2 diabetes mellitus and insulin resistance: Stroke prevention and management. Curr Treat Options Neurol 6: 443-450, 2004.
28. Lees KR, Walters MR. Acute stroke and diabetes. Cerebrovasc Dis 20 Suppl 1: 9-14, 2005.
29. LeMay D, Gehua L, Zelenock G, D'Alecy L. Insulin administration protects neurologic function in cerebral ischemia in rats. Stroke 19: 1411-1419, 1988.
30. Luck JM, Morrison G, Wilbur LF. The effect of insulin on the amino acid continent of blood. JBC: 151-156, 1928.
31. McCormick M, Hadley D, McLean J, Macfarlane J, Condon B, Muir K. Randomized, controlled trial of insulin for acute poststroke hyperglycemia. Ann Neurol 67: 570-578, 2010.
32. Nagy D, Marosi M, Kis Z, Farkas T, Rakos G, Vecsei L, Teichberg V, Toldi J. Oxaloacetate decreases the infarct size and attenuates the reduction in evoked responses after photothrombotic focal ischemia in the rat cortex. Cell Mol Neurobiol 29: 827-835, 2009.
33. Natale JE, Stante SM, D'Alecy LG. Elevated brain lactate accumulation and increased neurologic deficit are associated with modest hyperglycemia in global brain ischemia. Resuscitation 19: 271-289, 1990.
34. Nelson D, Cox M. Gluconeogenesis. In: Lehninger: Principles of Bio-chemistry, 4th ed., New York: Freeman, chap. 14, 2005, pp. 543-549.
35. Oddo M, Schmidt J, Carrera E, Badjatia N, Connolly E, Presciutti M, Ostapkovich N, Levine J, Le Roux P, Mayer A. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: A microdialysis study. Crit Care Med 36: 3233-3238, 2008.
36. Parsons M, Barber P, Desmond P, Baird T, Darby D, Byrnes G, Tress B, Davis S. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 58: 20-28, 2002.
37. Quinn T, Dawson J, Walters M. Sugar and stroke: Cerebrovascular disease and blood glucose control. Cardiovasc Ther In press.
38. Sandu O, Song K, Cai W, Zheng F, Uribarri J, Vlassara H. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes 54: 2314-2319, 2005.
39. Selim M. Perioperative stroke. N Engl J Med 356: 706-713, 2007.
40. Shafrir E. Animal Models of Diabetes, 2nd ed. CRC Press: London, 328 pp. 2007.
41. Tai E, Tan M, Stevens R, Low Y, Muehlbauer M, Goh D, Ilkayeva R, Wenner B, Bain J, Lee J, Lim CS, Khoo C, Shah S, Newgard C. Insulin resistance is associated with a metabolic profile of altered protein metab- olism in Chinese and Asian-Indian men. Diabetologia 53: 757-767, 2010.
42. Takagi K, Ginsberg M, D, Globus M, Y, Dietrich W, D, EM, Kraydieh S, Busto R. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology. J Cereb Blood Flow Metab 13: 575-585, 1993.
43. Tejima E, Katayama Y, Suzuki Y, Kano T, EHL. Hemorrhagic trans-formation after fibrinolysis with tissue plasminogen activator: evaluation of role of hypertension with rat thromboembolic stroke model. Stroke 32: 1336-1340, 2001.
44. Toni D, De Michele M, Fiorelli M, Bastianello S, Camerlingo M, Sacchetti M, Argentino C, Fieschi C. Influence of hyperglycaemia on infarct size and clinical outcome of acute ischemic stroke patients with intracranial arterial occlusion. J Neurol Sci 123: 129-133, 1994.
45. Warner D, Gionet T, Todd M, McAllister A. Insulin-induced normoglycemia improves ischemic outcome in hyperglycemic rats. Stroke 23: 1775-1789, 1992.
46. Wasserman D, Spalding J, Brooks L, Colburn C, Goldstein R, Cherrington A. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am J Physiol Endocrinol Metab 257: E108-E117, 1989.
47. Zlotnik A, Gurevich B, Tkachov S, Maoz I, Shapira Y, Teichberg VI. Brain neuroprotection by scavenging blood glutamate. Exp Neurol 203: 213-220, 2007.